New diabetes clinical trial: Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge

Published on: September 21, 2022 at 11:00AM
Condition:   Diabetes
Interventions:   Device: Continuous Glucose Monitor;   Device: Blood Glucose Monitor
Sponsors:   NYU Langone Health;   Abbott Diabetes Care Inc
Not yet recruiting
https://ift.tt/ZvgXD3G

Comments